Claims for Patent: 8,840,928

Summary for Patent: 8,840,928

Title:	Tamper-resistant pharmaceutical compositions of opioids and other drugs
Abstract:	Tamper-resistant pharmaceutical compositions have been developed to reduce the likelihood of improper administration of drugs, especially drugs such as opioids. The tamper-resistant compositions retard the release of drug, even if the physical integrity of the formulation is compromised (for example, by chopping with a blade or crushing) and the resulting material is placed in water, snorted, or swallowed. However, when administered as directed, the drug is slowly released from the composition as the composition is passes through the GI tract.
Inventor(s):	Rariy; Roman V. (Cherry Hill, NJ), Fleming; Alison B. (North Attleboro, MA), Hirsh; Jane C. (Wellesley, MA), Saim; Said (New Milford, CT), Varanasi; Ravi K. (Cumberland, RI)
Assignee:	Collegium Pharmaceutical, Inc. (Canton, MA)
Application Number:	12/965,572
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,840,928
Patent Claims:	1. A tamper resistant pharmaceutical composition comprising a plurality of solid particles each particle comprising a solid solution comprising: (a) one or more drugs prone to abuse; and (b) one or more fatty acids; wherein the one or more drugs interact ionically with the one or more fatty acids; and the one or more fatty acids comprise at least about 42%-69% by weight of the particle. 2. The tamper resistant composition of claim 1, wherein said drug is soluble in said one or more fatty acids when the one or more fatty acids are in their molten state. 3. The tamper resistant composition of claim 1, wherein said drug prone to abuse is an opioid analgesic. 4. The tamper resistant composition of claim 1, wherein the composition retards the release of a portion of the drug prone to abuse even it the physical integrity of the composition is compromised and the compromised composition is exposed to water. 5. The tamper resistant composition of claim 1 further comprising one or more anti-oxidants. 6. The tamper resistant composition of claim 1, further comprising one or more excipients having a low peroxide content in order to reduce oxidation of the drug or excipients. 7. The tamper resistant composition of claim 6, wherein the one or more excipients comprises carnauba wax having a peroxide value of less than 25 ppm. 8. The tamper resistant composition of claim 7, wherein the carnauba wax has a peroxide value of less than 5 ppm. 9. The tamper resistant composition of claim 7, wherein the carnauba wax has a peroxide value of less than 3 ppm. 10. The tamper resistant composition of claim 1, further comprising one or more substances used to change the dissolution behavior or the physical and/or chemical stability of the composition. 11. The tamper resistant composition of claim 10, wherein the one or more substances change the dissolution behavior of the composition. 12. The tamper resistant composition of claim 10, wherein the one or more substances comprises rate-controlling materials. 13. The tamper resistant composition of claim 12, wherein said rate-controlling materials comprise starch derivatives, cellulose derivatives, acrylic polymers, polyvinyl pyrrolidone, alginic acid, lactose, or mixtures thereof. 14. The tamper resistant composition of claim 12, wherein said rate-controlling materials comprise one or more pharmaceutically acceptable surfactants. 15. The tamper resistant composition of claim 14, wherein the one or more pharmaceutically acceptable surfactants comprise lecithin, sodium dodecyl sulfate, sodium salts of fatty acids, potassium salts of fatty acids, poloxamer, polyethoxylated castor oil, polyoxylglycerides, polysorbates, sorbitan stearate, or mixtures thereof. 16. The tamper resistant composition of claim 14, wherein the one or more pharmaceutically acceptable surfactants are applied to the surface to the particles, or are blended with the particles. 17. The tamper resistant composition of claim 1, wherein the particles are combined with one or more excipients and encapsulated into hard or soft shell capsules. 18. The tamper resistant composition of claim 17, wherein the one or more excipients are selected from the groups consisting of diluents, lubricants, gel forming excipients, and combinations thereof. 19. The tamper resistant composition of claim 17, wherein the hard shell capsules comprise hydroxypropylmethylcellulose. 20. a method of making the tamper resistant pharmaceutical composition of claim 1, comprising: (a) dispersing or dissolving a drug prone to abuse in one or more fatty acids; and (b) forming a plurality of particles comprising a solid solution comprising the drug in the one or more fatty acids via a spray congealing process from the material obtained in step (a) wherein the one or more fatty acids comprises 42%-69% by weight of the particle. 21. The method of claim 20, wherein the dissolving of said drug comprises a hot melt process. 22. The method of claim 20, wherein the dissolving of said drug comprises the use of a solvent or co-solvent. 23. The method of claim 20, wherein said spray congealing process comprises a spinning disc atomization process. 24. A tamper resistant pharmaceutical composition comprising a pluality of particles made by a process comprising forming a plurality of particles via a (i) a drag prone to abuse; and (ii) one or more fatty acids; wherein the drug prone to abuse interacts ionically with the one or more fatty acids; and the one or more fatty acids comprises 42%-69% by weight of the particle. 25. A tamper resistant pharmaceutical composition made by a process comprising the steps of: (a) dissolving a drug prone to abuse in one or more fatty acids; and (b) forming a plurality of particles comprising a solid solution comprising the drug in the one or more fatty acids via a spray congealing process from the material obtained in step (a) wherein the one or more fatty acids comprises 42%-69% by weight of the particle. 26. A method of treating pain comprising administering to a human subject in need thereof, a therapeutically effective amount of a tamper resistant pharmaceutical composition comprising a plurality of particles, each particle comprising a solid solution comprising: (a) one or more drugs prone to abuse; and (b) one or more fatty acids; wherein the drug prone to abuse interacts ionically with the one or more fatty acids and the one or more fatty acids comprises 42%-69% by weight of the particle. 27. The tamper resistant pharmaceutical composition of claim 1, wherein the drug prone to abuse is selected from the group consisting of oxycodone, oxymorphone, hydrocodone, morphine, and pharmaceutically acceptable salts thereof.